| Identification | More | [Name]
Sarafloxacin | [CAS]
98105-99-8 | [Synonyms]
SARAFLOXACIN
Sarafloxacinbase
6-Fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid
SARAFLOZACIN
6-Floro-1-(4-fluorophenyl)-1，4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoJinecarboxylic acid
Abbott 56620：A-56620
1,4-Dihydro-6-fluoro-7-(piperazine-1-yl)-1-(4-fluorophenyl)-4-oxoquinoline-3-carboxylic acid
6-Fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-piperazino-3-quinolinecarboxylic acid
A-56620 | [EINECS(EC#)]
1806241-263-5 | [Molecular Formula]
C20H17F2N3O3 | [MDL Number]
MFCD00865974 | [Molecular Weight]
385.36 | [MOL File]
98105-99-8.mol |
| Hazard Information | Back Directory | [Uses]
A Fluorinated quinolone antibacterial | [Uses]
Sarafloxacin is a quinolone antibiotic drug that was discontinued in 2001. Useful for biological studies and can be detected with colloidal gold test strips. | [Definition]
ChEBI: 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid is a member of quinolines. | [Brand name]
SaraFlox Injectable (Abbott); SaraFlox WSP (Abbott). |
|
|